Noveris Health Sciences is trading 5.88% up at CA$0.09 on September 15, 2026, with no clear company-specific catalyst identified.
- The latest reported announcement was shareholder approval of annual-meeting resolutions on September 9, including director elections.
- The broader market is modestly weaker, so current evidence does not support a direct macro explanation.
- The move appears speculative or liquidity-driven, with limited confirmed news available.